Alzheimer’s disease is a neurodegenerative condition that affects an estimated 7 million Americans.

The development of RI-AG03 represents more than just a potential treatment for Alzheimer’s. It opens up new avenues for drug discovery in the broader field of neurodegenerative diseases.

Their new peptide inhibitor, called RI-AG03, has been shown to prevent the build-up of harmful Tau proteins in the brain, a major factor in neurodegeneration. This breakthrough offers new hop ...

Developed by international researchers led by British experts, RI-AG03, tackles two 'hotspots' on the protein that leads to the memory robbing condition getting worse.

The AG03 is designed for the novice; however, for more seasoned users, the AG03 has compression and EQ settings that are fine-tuned by the AG DSP Controller. Once installed (in addition to the ...

They found that RI-AG03 penetrated the cells and reduced the aggregation of tau proteins, too. "What is new here, is that the authors have invented a molecule that binds to both tau hotspot regions.

An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer's Disease. For the first time, scientists have developed a drug that ...

Scientists have developed a new drug that targets two key regions of the tau protein, a major contributor to Alzheimer’s disease. The drug, a peptide inhibitor called RI-AG03, successfully ...

A peptide inhibitor called RI-AG03 targets major aggregation “hot spots” of tau proteins, believed to be a key driver of Alzheimer’s disease.

The increasing knowledge on how protein tau is organized in live cells has shown that the protein forms nanometer-sized hotspots which are different from tau microtubules. These hotspots, essential ...

"AG03-MIKU" was born in collaboration with Hatsune Miku which Kore arrived at the editorial department. It is a mixer equipped with 3 channels for music and sound, and it is connected to the PC ...